Tour de France cyclist fails drug detection test
Jul 13 2011
The cyclist is the first to be accused of doping in this year's event after testing positive for the diuretic hydrochlorothiazide in the first part of a urine sample which he provided on July 6th.
In a statement by the International Cycling Union, or UCI, it claimed that although a positive in the urine sample drug detection test would not force the Russian cyclist to retire from the race, he is taking the time out to prepare his defence.
Kolobnev will now have to give a second urine sample.
"If the B-sample also tests positive, he will be fired and will have to pay five times his salary as a fine," his team Katusha said on its website.
This year's Tour de France also made the headlines over the weekend when a camera car veered into cyclists, catapulting Johnny Hoogerland into a barbed wire fence.
In This Edition Modern & Practocal Applications - Accelerating ADC Development with Mass Spectrometry - Implementing High-Resolution Ion Mobility into Peptide Mapping Workflows Chromatogr...
View all digital editions
Oct 09 2022 New Orleans, LA, USA
Oct 11 2022 Lisbon, Portugal
Oct 12 2022 Telford, UK
Oct 23 2022 Hangzhou, China & Virtual
Nov 09 2022 Cleveland, OH, USA